There is no official contraindication or direct drug interaction between caffeine and semaglutide (marketed as Ozempic, Wegovy, and Rybelsus) listed in the FDA prescribing information
Consultado el 25 de septiembre de 2025: Wegovy FlexTouch (0,25 mg, 0,5 mg, 1 mg, 1,7 mg y 2,4 mg), EMA
Here is the short guide
This innovative GLP-1-based formula is designed to help curb appetite, promote weight loss, and support overall metabolic healthwithout the hassle of injections, refrigeration, or daily routines
Before the change, TFL beneficiaries who completed a rigorous prior-authorization process to validate obesity-related comorbid medical conditions could secure coverage for GLP-1 drugs approved for weight loss by the Food and Drug Administration (FDA)
This confuses a lot of people, so lets clear it up